Is Lung Cancer Hereditary? The Facts Explained

Lung cancer is not usually considered a strongly hereditary cancer in the same way as some breast, ovarian, or bowel cancers. However, family history can still influence risk. The picture is often complex, involving a combination of inherited susceptibility, environmental exposure, smoking history, age, and random genetic changes that develop during life.

Having a greater understanding of the difference between inherited risk and genetic changes within a tumour can help make this topic much clearer.

Lung cancer is usually not inherited directly

Most lung cancers are not passed directly from parent to child.

Cancer develops when cells acquire genetic changes that allow them to grow and divide abnormally. In lung cancer, many of these changes happen during a person’s lifetime rather than being inherited at birth. These are known as acquired mutations.

Acquired mutations may be linked to factors such as smoking, second-hand smoke, air pollution, occupational exposures, radon, or simply the natural ageing process of cells. They are found in the cancer cells themselves, not necessarily in every cell of the body.

Understanding how these acquired changes influence the disease is an important part of developing a personalised lung cancer treatment plan, as recommendations are increasingly guided by the biology of the tumour rather than family history alone.

This means a person can have genetic changes in their lung cancer without those changes being inherited or passed on to their children.

Family history can still affect lung cancer risk

Although most lung cancer is not directly inherited, having a close relative with lung cancer may increase risk.

A family history may reflect shared genes, shared environmental exposures, or both. For example, relatives may have lived in the same home, been exposed to similar levels of second-hand smoke, or shared certain workplace or environmental risk factors.

Cancer Research UK notes that lung cancer risk is higher when a close relative, such as a parent or sibling, has had lung cancer.

This does not mean that lung cancer is inevitable for relatives. It simply means that family history is one factor among many.

Hereditary risk and tumour genetics are not the same

One of the most common sources of confusion is the word "genetic."

Lung cancer can involve genetic mutations, but that does not automatically mean it is hereditary.

There are two broad categories to understand:

Inherited genetic changes are present from birth and can be passed through families. These are found in all cells of the body.

Tumour mutations develop within the cancer cells over time. These help explain how the cancer behaves and whether certain treatments may work.

In lung cancer care, tumour testing is often used after diagnosis to look for changes such as EGFR, ALK, ROS1, KRAS, and others. These results can influence whether targeted therapies or immunotherapy may be suitable.

This type of testing is not the same as testing whether relatives have inherited cancer risk.

Lung cancer in people who have never smoked

Lung cancer can occur in people who have never smoked.

This can understandably raise questions about genetics, especially when there is no obvious risk factor. In some patients, lung cancer may be linked to environmental exposures, radon, air pollution, previous lung disease, or tumour mutations that develop without a clear external cause.

Certain types of lung cancer in never-smokers are more likely to have targetable mutations, particularly in non-small cell lung cancer. This is one reason molecular testing can be especially important after diagnosis.

However, a diagnosis in a never-smoker does not automatically mean the cancer is hereditary. It means the underlying biology of the tumour should be carefully assessed.

When family history may need closer discussion

A single relative with lung cancer does not usually mean there is an inherited cancer syndrome in the family.

However, family history may deserve closer discussion if several close relatives have had lung cancer, cancers have occurred at unusually young ages, or there is a pattern of different cancers across generations.

In these situations, a GP, genetics service, or specialist team may be able to advise whether genetic counselling or further assessment is appropriate.

For most families, the more practical focus is understanding modifiable risk factors. Avoiding smoking, reducing exposure to second-hand smoke, addressing radon where relevant, and following occupational safety guidance can all help reduce risk.

Why molecular testing matters after diagnosis

Once lung cancer is diagnosed, one of the most important steps is understanding the biology of the tumour.

Molecular testing helps identify whether the cancer has specific features that may influence treatment. This can be particularly important in advanced non-small cell lung cancer, where targeted therapies or immunotherapy may be considered depending on the results.

These tests do not simply provide extra information. They can directly shape treatment decisions.

For example, some patients may be suitable for targeted therapies that act against specific genetic changes in the cancer. Others may benefit from immunotherapy, chemotherapy, radiotherapy, or a combination of approaches.

The purpose is to match treatment as closely as possible to the cancer’s behaviour.

What relatives should take from a lung cancer diagnosis

For relatives, the key message is balance.

A family history of lung cancer may increase risk, but it does not mean a diagnosis is inevitable. Risk is influenced by many factors, and many people with a family history will never develop lung cancer.

Relatives who are concerned should focus on practical steps such as avoiding smoking, seeking advice about persistent symptoms, and discussing screening eligibility with their GP if they have risk factors, including a significant smoking history.

For the person who has already been diagnosed, the priority is different. The focus shifts towards understanding the cancer type, stage, molecular profile, and the treatment options that are most appropriate for their individual diagnosis.

About Dr James Wilson

Questions about whether lung cancer is hereditary often lead to wider discussions about tumour biology, molecular testing, and personalised treatment.

Dr James Wilson is a consultant clinical oncologist in private practice in London with expertise in lung cancer, advanced radiotherapy, immunotherapy, targeted therapies, and systemic cancer care. He helps patients understand complex diagnoses and provides clear guidance around treatment options and second opinions.